Breaking News, Collaborations & Alliances

OctoPlus, Axentis in Service Pact

OctoPlus has signed a development and manufacturing contract with Axentis Pharma

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

OctoPlus N.V. has signed a pharmaceutical development and manufacturing contract with a new client, Axentis Pharma AG. OctoPlus will perform process development and clinical manufacturing of Axentis’ lead product, an inhalable liposomal formulation of tobramycin for the treatment of cystic fibrosis. Terms of the contract were not disclosed. OctoPlus provides formulation development and clinical material manufacturing services to biotech and pharmaceutical companies worldwide, as well as...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters